6-K 1 ea0257173-6k_work.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2025

 

Commission File Number: 001-42256

 

WORK Medical Technology Group LTD

 

Floor 23, No. 2 Tonghuinan Road

Xiaoshan District, Hangzhou City, Zhejiang Province

The People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

Results of WORK Medical Technology Group LTD’s Extraordinary General Meeting of Shareholders

 

The Extraordinary General Meeting of Shareholders (the “Meeting”) of WORK Medical Technology Group LTD (the “Company”) was held at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China, on September 12, 2025, at 9:30 a.m. EST, with the ability given to the shareholders to join virtually via live audio webcast at http://www.virtualshareholdermeeting.com/WOK2025SM.

 

At the close of business on August 20, 2025, the record date for the determination of shareholders entitled to vote at the Meeting, there were 53,699,442 Class A ordinary shares outstanding, each share being entitled to one vote, and 7,592,500 Class B ordinary shares (together with the Class A ordinary shares, the “Ordinary Shares”), each share being entitled to 20 votes, constituting all of the outstanding voting securities of the Company. At the Meeting, the holders of 28,106,006 Ordinary Shares of the Company, representing 160,488,506 votes, were represented in person or by proxy, constituting a quorum.

 

At the Meeting, the shareholders of the Company adopted the following resolutions:

 

1.An ordinary resolution to approve one or more share consolidations, subject to the determination of the consolidation ratio and timing by the board of directors of the Company;

 

2.An ordinary resolution to approve a share capital increase, subject to the determination of the aggregate authorized share capital increase and timing by the board of directors of the Company;

 

3.A special resolution to approve the Company’s adoption of a further amended and restated memorandum of association, conditional upon the approval of the proposed share capital increase, to reflect the relevant share consolidation and the relevant share capital increase upon their effectiveness; and

 

4.An ordinary resolution to approve any adjournment of the Meeting, if necessary.

 

The results of the vote at the Meeting for the resolutions were as follows:

 

*  For   Against   Abstain 
No. 1   141,283,402    91,722    23,258 
No. 2   141,281,969    91,154    25,259 
No. 3   159,772,692    538,712    177,102 
No. 4   159,773,176    538,068    177,262 

 

*The numbers in this column correspond to the resolutions enumerated in the third paragraph of this report.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: September 12, 2025

  

  WORK Medical Technology Group LTD
     
  By: /s/ Shuang Wu
  Name:  Shuang Wu
  Title:

Chief Executive Officer and

Chairman of the Board of Directors

 

2